Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
9 August 2013
Header
Header image
Highlight of the week

Highlight of the week

Blog open to comments
09 August 2013

EFPIA's blog is now open to comments - see at the bottom of a blog entry and connect with us!

http://www.efpia.eu/media/blog

Read more

From our blog

From our blog

Data Sharing Workshop Offers Opportunity to Bring Different Opinions to One Table
08 August 2013 by Richard Bergström

Diverse opinions are needed to find the best solutions – this is a point I strongly believe in and it’s why last week I emphasised [...] Read more

From our blog

Value through the medicines lifecycle….
07 August 2013 by Richard Torbett

The UK’s National Institute for Health and Clinical Excellence (NICE) has had its fair share of headlines over the decade since it was created to [...] Read more

Videos

Video

Efpia 2013 Annual Meetings - Paul Krugman (Q&A)

EFPIA Director General Richard Bergström introduces Paul Krugman, Keynote Speaker Nobel Prize winning economist at the 2013 EFPIA Annual meeting - followed by a Q & A moderated by Peter Spiegel (NY Times).

View video

Video

The Importance of Clinical Trials

The Importance of Clinical Trials voiced by EFPIA Director General Richard Bergström.

View video

Events calendar

Events Calendar

Roundtable by the European Alliance for Personalised Medicine
On 10/09/2013 (European Parliament, Strasbourg, France)

'The right prevention and treatment to the right patient at the right time'  A Roundtable Event Hosted in the European Parliament  European Parliament, StrasbourgTuesday 10 September 2013 The [...] Read more

What we are reading

What we are reading

NIH director explains HeLa agreement
09 August 2013

This week it was decided that the descendants of Henrietta Lacks, a young black woman whose cells were taken without her consent and used in more than 70,000 medical studies since 1951, will help determine how that data is used.
 
Any scientist receiving National Institutes of Health (NIH) funds to study the HeLa cell genome must apply to a panel that includes scientists as well as two of Lacks's descendants for access to the information. The journal Nature published the guidelines this week. We thought the publication's interview with NIH director Francis Collins, who explains the agreement and its motivation, was a great read. 
 
(photo of Henrietta Lacks)
Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail